Literature DB >> 29558861

Relationships Among Apathy, Health-Related Quality of Life, and Function in Huntington's Disease.

Nora E Fritz1, Nicholas R Boileau1, Julie C Stout1, Rebecca Ready1, Joel S Perlmutter1, Jane S Paulsen1, Kimberly Quaid1, Stacey Barton1, Michael K McCormack1, Susan L Perlman1, Noelle E Carlozzi1.   

Abstract

Up to 90% of individuals with Huntington's disease (HD)-a progressive, inherited neurodegenerative disorder-experience apathy. Apathy is particularly debilitating because it is marked by a reduction in goal-directed behaviors, including self-care, social interactions, and mobility. The objective of this study was to examine relationships between variables of apathy, functional status, physical function, cognitive function, behavioral status/emotional function, and health-related quality of life. Clinician-rated measures of physical, cognitive, and behavioral function, including one clinician-rated item on apathy, and self-reported measures of physical function, health-related quality of life, and emotional, cognitive, and social function were collected in a single session from 487 persons with the HD mutation (prodromal, N=193; early-stage manifest, N=186; late-stage manifest, N=108). Multiple linear regression models were used to examine which outcomes best predicted clinician-rated apathy after controlling for disease stage. Greater apathy related to less independence, increased motor impairment, and more clinician-rated behavioral problems (i.e., anger, irritability, depression). Similarly, poorer self-reported health-related quality of life; greater chorea; greater upper- and lower-extremity dysfunction; greater speech and swallowing dysfunction; worse anxiety, depression, and behavioral dyscontrol; worse cognitive function; and less satisfaction with social roles related to greater apathy. In conclusion, apathy related to physical, cognitive, and behavioral dysfunction across disease stages. Future work should explore whether clinical interventions targeting different functional domains may have the potential to reduce apathy in this patient population.

Entities:  

Keywords:  Apathy; Health-Related Quality of Life; Huntington-s Disease

Mesh:

Year:  2018        PMID: 29558861      PMCID: PMC6081241          DOI: 10.1176/appi.neuropsych.17080173

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  37 in total

Review 1.  EQ-5D: a measure of health status from the EuroQol Group.

Authors:  R Rabin; F de Charro
Journal:  Ann Med       Date:  2001-07       Impact factor: 4.709

2.  Behavioural abnormalities contribute to functional decline in Huntington's disease.

Authors:  J M Hamilton; D P Salmon; J Corey-Bloom; A Gamst; J S Paulsen; S Jerkins; M W Jacobson; G Peavy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

3.  New measures to capture end of life concerns in Huntington disease: Meaning and Purpose and Concern with Death and Dying from HDQLIFE (a patient-reported outcomes measurement system).

Authors:  N E Carlozzi; N R Downing; M K McCormack; S G Schilling; J S Perlmutter; E A Hahn; J S Lai; S Frank; K A Quaid; J S Paulsen; D Cella; S M Goodnight; J A Miner; M A Nance
Journal:  Qual Life Res       Date:  2016-07-08       Impact factor: 4.147

4.  Correlates of apathy in Huntington's disease.

Authors:  E van Duijn; N Reedeker; E J Giltay; R A C Roos; R C van der Mast
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2010       Impact factor: 2.198

5.  Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease.

Authors:  Jennifer C Thompson; Jenny Harris; Andrea C Sollom; Cheryl L Stopford; Elizabeth Howard; Julie S Snowden; David Craufurd
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2012       Impact factor: 2.198

6.  Health-related quality of life in Huntington's disease: Which factors matter most?

Authors:  Aileen K Ho; Abigail S Gilbert; Sarah L Mason; Anna O Goodman; Roger A Barker
Journal:  Mov Disord       Date:  2009-03-15       Impact factor: 10.338

7.  The development of a new computer adaptive test to evaluate chorea in Huntington disease: HDQLIFE Chorea.

Authors:  N E Carlozzi; N R Downing; S G Schilling; J-S Lai; S M Goodnight; J A Miner; S A Frank
Journal:  Qual Life Res       Date:  2016-05-03       Impact factor: 4.147

8.  Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.

Authors:  Sarah J Tabrizi; Rachael I Scahill; Gail Owen; Alexandra Durr; Blair R Leavitt; Raymund A Roos; Beth Borowsky; Bernhard Landwehrmeyer; Chris Frost; Hans Johnson; David Craufurd; Ralf Reilmann; Julie C Stout; Douglas R Langbehn
Journal:  Lancet Neurol       Date:  2013-05-09       Impact factor: 44.182

9.  The World Health Organization Disability Assessment Scale, WHODAS II: reliability and validity in the measurement of activity and participation in a spinal cord injury population.

Authors:  Annelies C Wolf; Robyn L Tate; Natasha A Lannin; James Middleton; Amanda Lane-Brown; Ian D Cameron
Journal:  J Rehabil Med       Date:  2012-09       Impact factor: 2.912

10.  Huntington's disease from the patient, caregiver and physician's perspectives: three sides of the same coin?

Authors:  Krzysztof Banaszkiewicz; Emilia J Sitek; Monika Rudzińska; Witold Sołtan; Jarosław Sławek; Andrzej Szczudlik
Journal:  J Neural Transm (Vienna)       Date:  2012-03-08       Impact factor: 3.575

View more
  12 in total

1.  Perceptions of the impact of chorea on health-related quality of life in Huntington disease (HD): A qualitative analysis of individuals across the HD spectrum, family members, and clinicians.

Authors:  Carey Wexler Sherman; Ravi Iyer; Victor Abler; Alexandria Antonelli; Noelle E Carlozzi
Journal:  Neuropsychol Rehabil       Date:  2019-03-08       Impact factor: 2.868

2.  End-of-life measures in Huntington disease: HDQLIFE Meaning and Purpose, Concern with Death and Dying, and End of Life Planning.

Authors:  Noelle E Carlozzi; Nicholas R Boileau; Jane S Paulsen; Joel S Perlmutter; Jin-Shei Lai; Elizabeth A Hahn; Michael K McCormack; Martha A Nance; David Cella; Stacey K Barton; Nancy R Downing
Journal:  J Neurol       Date:  2019-06-12       Impact factor: 4.849

3.  Apathy Associated With Impaired Recognition of Happy Facial Expressions in Huntington's Disease.

Authors:  Katherine Osborne-Crowley; Sophie C Andrews; Izelle Labuschagne; Akshay Nair; Rachael Scahill; David Craufurd; Sarah J Tabrizi; Julie C Stout
Journal:  J Int Neuropsychol Soc       Date:  2019-02-15       Impact factor: 2.892

4.  Multidimensional Apathy: The Utility of the Dimensional Apathy Scale in Huntington's Disease.

Authors:  Kelly J Atkins; Sophie C Andrews; Trevor T-J Chong; Julie C Stout
Journal:  Mov Disord Clin Pract       Date:  2021-02-12

5.  Efficacy of serious exergames in improving neuropsychiatric symptoms in neurocognitive disorders: Results of the X-TORP cluster randomized trial.

Authors:  Philippe Robert; Claire Albrengues; Roxane Fabre; Alexandre Derreumaux; Marie Pierre Pancrazi; Isabelle Luporsi; Bruno Dubois; Stéphane Epelbaum; Grégoire Mercier; Pierre Foulon; François Bremond; Valeria Manera
Journal:  Alzheimers Dement (N Y)       Date:  2021-05-11

6.  Self-Reported Social Relationship Capacities Predict Motor, Functional and Cognitive Decline in Huntington's Disease.

Authors:  Pablo Lemercier; Laurent Cleret de Langavant; Jennifer Hamet Bagnou; Katia Youssov; Laurie Lemoine; Etienne Audureau; Renaud Massart; Anne-Catherine Bachoud-Lévi
Journal:  J Pers Med       Date:  2022-01-27

Review 7.  Social Withdrawal in Huntington's Disease: A Scoping Review.

Authors:  Jessie S Gibson; Kristen Springer
Journal:  J Huntingtons Dis       Date:  2022

8.  Apathy Is Related to Cognitive Control and Striatum Volumes in Prodromal Huntington's Disease.

Authors:  Maria B Misiura; Jennifer Ciarochi; Jatin Vaidya; Jeremy Bockholt; Hans J Johnson; Vince D Calhoun; Jane S Paulsen; Jessica A Turner
Journal:  J Int Neuropsychol Soc       Date:  2019-02-26       Impact factor: 2.892

9.  Family Functioning and Multiple Sclerosis: Study Protocol of a Multicentric Italian Project.

Authors:  Marialaura Di Tella; Virginia Perutelli; Giuseppina Miele; Luigi Lavorgna; Simona Bonavita; Stefania Federica De Mercanti; Lidia Mislin Streito; Marinella Clerico; Lorys Castelli
Journal:  Front Psychol       Date:  2021-06-09

10.  Are the Items of the Starkstein Apathy Scale Fit for the Purpose of Measuring Apathy Post-stroke?

Authors:  Stanley Hum; Lesley K Fellows; Christiane Lourenco; Nancy E Mayo
Journal:  Front Psychol       Date:  2021-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.